Genetic modulation of sickle cell disease

Renaissance of Sickle Cell Disease Research in the Genome Era

Volumn , Issue , 2007, Pages 193-206

  Steinberg, Martin H ^a   Thein, Swee Lay ^b  

^a BOSTON MEDICAL CENTER   (United States)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84967684029     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9781860947964_0012     Document Type: Chapter

References (72)

1. Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. (1996). Sickle Cell Disease: Basic Principles and Clinical Practice. Philadelphia, NY: Lippincott-Raven Publishers.
2. Amin BR, Bauersachs RM, Meiselman HJ, Mohandas N, Hebbel RP, Bowen PE, Schlegel RA, Williamson P, Westerman MP (1991). Monozygotic twins with sickle cell anemia and discordant clinical courses: clinical and laboratory studies. Hemoglobin 15:247-256.
3. Joishy SK, Griner PF, Rowley PT (1976). Sickle β-thalassemia: identical twins differing in severity implicate nongenetic factors influencing course. Am J Hematol 1:23-33.
4. Garner C, Tatu T, Reittie JE, Littlewood T, Darley J, Cervino S, Farrall M, Kelly P, Spector TD, Thein SL (2000). Genetic influences on F cells and other hematologic variables: a twin heritability study. Blood 95:342-346.
5. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, Lundin P, Maner S, Massa H, Walker M, Chi M, Navin N, Lucito R, Healy J, Hicks J, Ye K, Reiner A, Gilliam TC, Trask B, Patterson N, Zetterberg A, Wigler M (2004). Large-scale copy number polymorphism in the human genome. Science 305:525-528.
6. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, Scherer SW, Lee C (2004). Detection of large-scale variation in the human genome. Nat Genet 36:949-951.
7. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, Sherry S, Mullikin JC, Mortimore BJ, Willey DL, Hunt SE, Cole CG, Coggill PC, Rice CM, Ning Z, Rogers J, Bentley DR, Kwok PY, Mardis ER, Yeh RT, Schultz B, Cook L, Davenport R, Dante M, Fulton L, Hillier L, Waterston RH, McPherson JD, Gilman B, Schaffner S, Van Etten WJ, Reich D, Higgins J, Daly MJ, Blumenstiel B, Baldwin J, Stange-Thomann N, Zody MC, Linton L, Lander ES, Altshuler D (2001). A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. The International SNP Map Working Group. Nature 409:928-933.
8. Venter JC, Adams MD, Myers EW et al. (2001). The sequence of the human genome. Science 291: 1304-1351.
9. Lander ES, Linton LM, Birren B, Nusbaum C et al. (2001). Initial sequencing and analysis of the human genome. Nature 409:860-921.
10. Syvanen AC (2005). Toward genome-wide SNP genotyping. Nat Genet 37(Suppl):S5-10.
11. Collins FS, Morgan M, Patrinos A (2003). The Human Genome Project: lessons from large-scale biology. Science 300:286-290.
12. Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES (2001). High-resolution haplotype structure in the human genome. Nat Genet 29:229-232.
13. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D (2002). The structure of haplotype blocks in the human genome. Science 296:2225-2229.
14. The International HapMap Project (2003). Nature 426:789-796.
15. Reich DE, Cargill M, Bolk S, Ireland J, Sabeti PC, Richter DJ, Lavery T, Kouyoumjian R, Farhadian SF, Ward R, Lander ES (2001). Linkage disequilibrium in the human genome. Nature 411:199-204.
16. Hirschhorn JN, Daly MJ (2005). Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6:95-108.
17. Powars DR, Weiss JN, Chan LS, Schroeder WA (1984). Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia. Blood 63:921-926.
18. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR (1995). Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia. N Engl J Med 332:1317-1322.
19. Perrine SP, Ginder GD, Faller DV, Dover GH, Ikuta T, Witkowska HE, Cai SP, Vichinsky EP, Olivieri NF (1993). A short-term trial of butyrate to stimulate fetal-globin-gene expression in the β globin disorders. N Engl J Med 328:81-86.
20. Atweh GF, Sutton M, Nassif I, Boosalis V, Dover GJ, Wallenstein S, Wright E, McMahon L, Stamatoyannopoulos G, Faller DV, Perrine SP (1999). Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease. Blood 93:1790-1797.
21. Steinberg MH, Voskaridou E, Kutlar A, Loukopoulos D, Koshy M, Ballas SK, Castro O, Barton F (2003). Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease. Am J Hematol 72:121-126.
22. Blobel GA, Weiss MJ (2001). Nuclear factors that regulate erythropoeisis. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, editors. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. Cambridge UK: Cambridge University Press, pp. 72-94.
23. Wood WG (1993). Increased HbF in adult life. In: Higgs DR, Weatherall DJ, editors. Baillière’s Clinical Haematology: International Practice and Research. London: Baillière Tindall, W.B. Saunders, Vol. 6, pp. 177-213.
24. Gγ globin production. Blood 66:783-787.
25. Garner C, Tatu T, Game L et al. (2000). A candidate gene study of F cell levels in sibling pairs using a joint linkage and association analysis. Gene Screen 1:9-14.
26. Wood WG (2001). Hereditary persistence of fetal hemoglobin and delta beta thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, editors. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. Cambridge, UK: Cambridge University Press, pp. 356-388.
27. Thein SL, Hesketh C, Wallace RB, Weatherall DJ (1988). The molecular basis of thalassaemia major and thalassaemia intermedia in Asian Indians: application to prenatal diagnosis. Br J Haematol 70:225-231.
28. Labie D, Pagnier J, Lapoumeroulie C, Rouabhi F, Dunda-Belkhodja O, Chardin P, Beldjord C, Wajcman H, Fabry ME, Nagel RL (1985). Common haplotype dependency of high Ggamma-globin gene expression and high HbF levels in beta-thalassemia and sickle cell anemia patients. Proc Natl Acad Sci USA 82:2111-2114.
29. Nagel RL, Fabry ME, Pagnier J, Zohoun I, Wajcman H, Baudin V, Labie D (1985). Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type. N Engl J Med 312:880-884.
30. Steinberg MH, Hsu H, Nagel RL, Milner PF, Adams JG, Benjamin L, Fryd S, Gillette P, Gilman J, Josifovska O et al. (1995). Gender and haplotype effects upon hematological manifestations of adult sickle cell anemia. Am J Hematol 48:175-181.
31. s globin haplotypes in an Indian population with sickle cell disease. Blood 69:1742-1746.
32. Dover GJ, Smith KD, Chang YC, Milner PF, Adams JG, Benjamin L, Fryd S, Gillette P, Gilman J, Josifovska O et al. (1992). Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2. Blood 80:816-824.
33. Thein SL, Sampietro M, Rohde K, Rochette J, Weatherall DJ, Lathrop GM, Demenais F (1994). Detection of a major gene for heterocellular hereditary persistence of fetal hemoglobin after accounting for genetic modifiers. Am J Hum Genet 54:214-228.
34. Craig JE, Rochette J, Fisher CA, Weatherall DJ, Marc S, Lathrop GM, Demenais F, Thein SL (1996). Dissecting the loci controlling fetal haemoglobin production on chromosomes 11p and 6q by the regressive approach. Nat Genet 12:58-64.
35. Close J, Game L, Clark BE, Bergounioux J, Gerovassili A, Thein SL (2004). Genome annotation of a 1.5 Mb region of human chromosome 6q23 encompassing a quantitative trait locus for fetal hemoglobin expression in adults. BMC Genom 5:33.
36. Garner C, Tatu T, Best S, Creary L, Thein SL (2002). Evidence for genetic interaction between the betaglobin complex and chromosome 8q in the expression of fetal hemoglobin. Am J Hum Genet 70:793-799.
37. Garner C, Silver N, Best S, Menzel S, Martin C, Spector TD, Thein SL (2004). Quantitative trait locus on chromosome 8q influences the switch from fetal to adult hemoglobin. Blood 104:2184-2186.
38. Garner C, Menzel S, Martin C, Silver N, Best S, Spector TD, Thein SL (2005). Interaction between two quantitative trait loci affects fetal hemoglobin expression. Ann Hum Genet 69:707-714.
39. Wyszynski DF, Baldwin CT, Cleves MA, Amirault Y, Nolan VG, Farrell JJ, Bisbee A, Kutlar A, Farrer LA, Steinberg MH (2004). Polymorphisms near a chromosome 6q QTL area are associated with modulation of fetal hemoglobin levels in sickle cell anemia. Cell Mol Biol (Noisy-le-grand) 50:23-33.
40. Craig JE, Rochette J, Sampietro M, Wilkie AO, Barnetson R, Hatton CS, Demenais F, Thein SL (1997). Genetic heterogeneity in heterocellular hereditary persistence of fetal hemoglobin. Blood 90:428-434.
41. S gene: Origins, genetic epidemiology, and epistasis in sickle cell anemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, editors. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. Cambridge, UK: Cambridge University Press, pp. 711-755.
42. Powars DR (1991). Sickle cell anemia: beta S-gene-cluster haplotypes as prognostic indicators of vital organ failure. Semin Hematol 28:202-208.
43. Steinberg MH, Embury SH (1986). Alpha-thalassemia in blacks: genetic and clinical aspects and interactions with the sickle hemoglobin gene. Blood 68:985-990.
44. Embury SH, Dozy AM, Miller J, Davis JR Jr, Kleman KM, Preisler H, Vichinsky E, Lande WN, Lubin BH, Kan YW, Mentzer WC (1982). Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia. N Engl J Med 306:270-274.
45. Steinberg MH, Rosenstock W, Coleman MB et al. (1984). Effects of thalassemia and microcytosis on the hematologic and vasoocclusive severity of sickle cell anemia. Blood 63:1353-1360.
46. Thomas PW, Higgs DR, Serjeant GR (1997). Benign clinical course in homozygous sickle cell disease: a search for predictors. J Clin Epidemiol 50:121-126.
47. Alexander N, Higgs D, Dover G, Serjeant GR (2004). Are there clinical phenotypes of homozygous sickle cell disease? Br J Haematol 126:606-611.
48. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR (1991). Pain in sickle cell disease: rates and risk factor. N Engl J Med 325:11-16.
49. Russell MO, Goldberg HI, Hodson A, Kim HC, Halus J, Reivich M, Schwartz E (1984). Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood 63:162-169.
50. Driscoll MC, Hurlet A, Styles L, McKie V, Files B, Olivieri N, Pegelow C, Berman B, Drachtman R, Patel K, Brambilla D (2003). Stroke risk in siblings with sickle cell anemia. Blood 101:2401-2404.
51. Taylor JG, Tang DC, Savage SA, Leitman SF, Heller SI, Serjeant GR, Rodgers GP, Chanock SJ (2002). Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood 100:4303-4309.
52. Hoppe C, Klitz W, Cheng S, Apple R, Steiner L, Robles L, Girard T, Vichinsky E, Styles L (2004). Gene interactions and stroke risk in children with sickle cell anemia. Blood 103:2391-2396.
53. Styles L, Hoppe C, Klitz W, Vichinsky E, Lubin B, Trachtenberg E (2000). Evidence for HLA-related susceptibility for stroke in children with sickle cell disease. Blood 95:3562-3567.
54. Hoppe C, Klitz W, Noble J, Vigil L, Vichinsky E, Styles L (2003). Distinct HLA associations by stroke subtype in children with sickle cell anemia. Blood 101:2865-2869.
55. Sebastiani P, Ramoni MF, Nolan V, Baldwin CT, Steinberg MH (2005). Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat Genet 37:435-440.
56. Nolan VG, Baldwin C, Ma Q, Wyszynski DF, Amirault Y, Farrell JJ, Bisbee A, Embury SH, Farrer LA, Steinberg MH (2005). Association of single nucleotide polymorphisms in klotho with priapism in sickle cell anaemia. Br J Haematol 128:266-272.
57. Kutlar F, Tural C, Park D, Markowitz RB, Woods KF, Kutlar A (1998). MTHFR (5,10 methylenetetrahydrofolate reductase) 677→T mutation as a candidate risk factor for avascular necrosis (AVN) in patients with sickle cell disease. Blood 92:695a.
58. Zimmerman SA, Ware RE (1998). Inherited DNA mutations contributing to thrombotic complications in patients with sickle cell disease. Am J Hematol 59:267-272.
59. Baldwin C, Nolan VG, Wyszynski DF, Ma QL, Sebastiani P, Embury SH, Bisbee A, Farrell J, Farrer L, Steinberg MH (2005). Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis. Blood 106:372-375.
60. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, Brown B, Coles WA, Nichols JS, Ernst I, Hunter LA, Blackwelder WC, Schechter AN, Rodgers GP, Castro O, Ognibene FP (2004). Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 350:886-895.
61. Sharan K, Surrey S, Ballas S, Borowski M, Devoto M, Wang KF, Sandler E, Keller M (2004). Association of T-786C eNOS gene polymorphism with increased susceptibility to acute chest syndrome in females with sickle cell disease. Br J Haematol 124:240-243.
62. Sullivan KJ, Kissoon N, Duckworth LJ, Sandler E, Freeman B, Bayne E, Sylvester JE, Lima JJ (2001). Low exhaled nitric oxide and a polymorphism in the NOS I gene is associated with acute chest syndrome. Am J Respir Crit Care Med 164:2186-2190.
63. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, Lindhout D, Tytgat GN, Jansen PL, Oude Elferink RP et al. (1995). The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert’s syndrome. N Engl J Med 333:1171-1175.
64. Passon RG, Howard TA, Zimmerman SA, Schultz WH, Ware RE (2001). Influence of bilirubin uridine diphosphate-glucuronosyltransferase 1A promoter polymorphisms on serum bilirubin levels and cholelithiasis in children with sickle cell anemia. Am J Pediatr Hematol Oncol 23:448-451.
65. Fertrin KY, Melo MB, Assis AM, Saad ST, Costa FF (2003). UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia. Clin Genet 64:160-162.
66. Heeney MM, Howard TA, Zimmerman SA, Ware RE (2003). UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell anemia. J Lab Clin Med 141:279-282.
67. Haverfield EV, McKenzie CA, Forrester T, Bouzekri N, Harding R, Serjeant G, Walker T, Peto TE, Ward R, Weatherall DJ (2004). UGT1A1 variation and gallstone formation in sickle cell disease. Blood 105:968-972.
68. Castro V, Alberto FL, Costa RN, Lepikson-Neto J, Gualandro SF, Figueiredo MS, Annichino-Bizzacchi JM, Saad ST, Costa FF (2004). Polymorphism of the human platelet antigen-5 system is a risk factor for occlusive vascular complications in patients with sickle cell anemia. Vox Sang 87:118-123.
69. Miller ST, Sleeper LA, Pegelow CH, Enos LE, Wang WC, Weiner SJ, Wethers DL, Smith J, Kinney TR (2000). Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 342:83-89.
70. Tang DC, Prauner R, Liu W, Kim KH, Hirsch RP, Driscoll MC, Rodgers GP (2001). Polymorphisms within the angiotensinogen gene (GT-repeat) and the risk of stroke in pediatric patients with sickle cell disease: a case-control study. Am J Hematol 68:164-169.
71. De Castro L, Rinder HM, Howe JG, Smith BR (1998). Thrombophilic genotypes do not adversely affect the course of sickle cell disease (SCD). Blood 92:161a.
72. Zimmerman SA, Howard TA, Whorton MR, Rosse WF, Ware RE (1998). The A312G polymorphism in alpha-fibrinogen is associated with stroke and avascular necrosis in patients with sickle cell anemia. Blood 92:36b.